-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
"The national drug centralized procurement policy has guided drug prices back to a reasonable level and reduced the burden on the masses of drugs, but it needs to be optimized.
Zhang Guogang introduced that in the past two years, the national drug centralized procurement reform has achieved breakthrough results.
Centralized procurement of drugs with volume is an important measure to coordinate the reform of the supply side of medical services.
However, Zhang Guogang found in his investigation that there are also many problems in the national centralized drug procurement.
"Medicine is a subject that is constantly updated and iterative.
In order to optimize the management of national centralized procurement of drugs, Zhang Guogang suggested that the selection of national centralized procurement of drugs should be combined with the latest clinical diagnosis and treatment standards, and the recommendations of clinical doctors and pharmacists should be widely solicited to ensure that the selected species in centralized procurement are clinically used drugs.
"During the clinical diagnosis and treatment process, pharmacists assist in formulating dosing plans, conduct prescription/doctoral order review, monitor and evaluate the efficacy and safety of drugs, and ensure the clinical safety and reasonable application of drugs.
"The national drug centralized procurement policy has guided drug prices back to a reasonable level and reduced the burden on the masses of drugs, but it needs to be optimized.